The FDA just picked its first company to sell an unauthorised device to Medicare patients
Source: The Next Web· Alina Maria Stan· July 27, 2026
The US Food and Drug Administration named Dexcom as the first manufacturer selected for its Technology-Enabled Meaningful Patient Outcomes pilot on Tuesday. The programme, known as TEMPO, allows digital health devices to be offered to Medicare patients before…
This story was reported by The Next Web. Read the full original article:
Read on The Next Web 
